tetano
Editor, Senior Moderator
J Stroke Cerebrovasc Dis
. 2021 Apr 8;30(7):105805.
doi: 10.1016/j.jstrokecerebrovasdis.2021.105805. Online ahead of print.
Outcomes of COVID-19 Complications and their Possibilities as Potential Triggers of Stroke
Urvish Patel[SUP] 1 [/SUP], Preeti Malik[SUP] 2 [/SUP], Deep Mehta[SUP] 3 [/SUP], Priyanka Rajput[SUP] 4 [/SUP], Mashu Shrivastava[SUP] 5 [/SUP], Madiha Naveed[SUP] 6 [/SUP], Eseosa Urhoghide[SUP] 7 [/SUP], Mehwish Martin[SUP] 1 [/SUP], Shamima Somi[SUP] 8 [/SUP], Richa Jaiswal[SUP] 9 [/SUP], Achint Patel[SUP] 1 [/SUP], Avantika Israni[SUP] 10 [/SUP], Jagmeet Singh[SUP] 11 [/SUP], Asim Kichloo[SUP] 12 [/SUP], Shamik Shah[SUP] 13 [/SUP], Abhishek Lunagariya[SUP] 14 [/SUP]
Affiliations
Abstract
Introduction: There is limited literature on coronavirus disease 2019 (COVID -19) complications such as thromboembolism, cardiac complications etc. as possible trigger for stroke. Hence, we aim to evaluate the prevalence and outcomes of COVID-19 related cardiovascular complications and secondary infection and their possibility as potential triggers for the stroke.
Methods: Data from observational studies describing the complications [acute cardiac injury (ACI), cardiac arrhythmias (CA), disseminated intravascular coagulation (DIC), septic shock, secondary infection] and outcomes of COVID-19 hospitalized patients from December 1, 2019 to June 30, 2020, were extracted following PRISMA guidelines. Adverse outcomes defined as intensive care units, oxygen saturation less than 90%, invasive mechanical ventilation, severe disease, and in-hospital mortality. The odds ratio and 95% confidence interval were obtained, and forest plots were created using random-effects models. A short review of these complications as triggers of stroke was conducted.
Results: 16 studies with 3480 confirmed COVID-19 patients, prevalence of ACI [38%vs5.9%], CA [26%vs5.3%], DIC [4%vs0.74%], septic shock [18%vs0.36%], and infection [30%vs12.5%] was higher among patients with poor outcomes. In meta-analysis, ACI [aOR:9.93(95%CI:3.95-25.00], CA [7.52(3.29-17.18)], DIC [7.36(1.24-43.73)], septic shock [30.12(7.56-120.10)], and infection [10.41(4.47-24.27)] had higher odds of adverse outcomes. Patients hospitalized with acute ischemic stroke and intracerebral hemorrhage, had complications like pulmonary embolism, venous thromboembolism, DIC, etc. and had poor outcomes CONCLUSION: The complications like acute cardiac injury, cardiac arrhythmias, DIC, septic shock, and secondary infection had poor outcomes. Patients with stroke were having history of these complications. Long term monitoring is required in such patients to prevent stroke and mitigate adverse outcomes.
Keywords: COVID-19; Cardiac arrhythmia; Coronary Artery Disease; Deep vein thrombosis; Disseminated intravascular coagulation; Pulmonary embolism; Septic shock; Stroke.
. 2021 Apr 8;30(7):105805.
doi: 10.1016/j.jstrokecerebrovasdis.2021.105805. Online ahead of print.
Outcomes of COVID-19 Complications and their Possibilities as Potential Triggers of Stroke
Urvish Patel[SUP] 1 [/SUP], Preeti Malik[SUP] 2 [/SUP], Deep Mehta[SUP] 3 [/SUP], Priyanka Rajput[SUP] 4 [/SUP], Mashu Shrivastava[SUP] 5 [/SUP], Madiha Naveed[SUP] 6 [/SUP], Eseosa Urhoghide[SUP] 7 [/SUP], Mehwish Martin[SUP] 1 [/SUP], Shamima Somi[SUP] 8 [/SUP], Richa Jaiswal[SUP] 9 [/SUP], Achint Patel[SUP] 1 [/SUP], Avantika Israni[SUP] 10 [/SUP], Jagmeet Singh[SUP] 11 [/SUP], Asim Kichloo[SUP] 12 [/SUP], Shamik Shah[SUP] 13 [/SUP], Abhishek Lunagariya[SUP] 14 [/SUP]
Affiliations
- PMID: 33892314
- PMCID: PMC8026256
- DOI: 10.1016/j.jstrokecerebrovasdis.2021.105805
Abstract
Introduction: There is limited literature on coronavirus disease 2019 (COVID -19) complications such as thromboembolism, cardiac complications etc. as possible trigger for stroke. Hence, we aim to evaluate the prevalence and outcomes of COVID-19 related cardiovascular complications and secondary infection and their possibility as potential triggers for the stroke.
Methods: Data from observational studies describing the complications [acute cardiac injury (ACI), cardiac arrhythmias (CA), disseminated intravascular coagulation (DIC), septic shock, secondary infection] and outcomes of COVID-19 hospitalized patients from December 1, 2019 to June 30, 2020, were extracted following PRISMA guidelines. Adverse outcomes defined as intensive care units, oxygen saturation less than 90%, invasive mechanical ventilation, severe disease, and in-hospital mortality. The odds ratio and 95% confidence interval were obtained, and forest plots were created using random-effects models. A short review of these complications as triggers of stroke was conducted.
Results: 16 studies with 3480 confirmed COVID-19 patients, prevalence of ACI [38%vs5.9%], CA [26%vs5.3%], DIC [4%vs0.74%], septic shock [18%vs0.36%], and infection [30%vs12.5%] was higher among patients with poor outcomes. In meta-analysis, ACI [aOR:9.93(95%CI:3.95-25.00], CA [7.52(3.29-17.18)], DIC [7.36(1.24-43.73)], septic shock [30.12(7.56-120.10)], and infection [10.41(4.47-24.27)] had higher odds of adverse outcomes. Patients hospitalized with acute ischemic stroke and intracerebral hemorrhage, had complications like pulmonary embolism, venous thromboembolism, DIC, etc. and had poor outcomes CONCLUSION: The complications like acute cardiac injury, cardiac arrhythmias, DIC, septic shock, and secondary infection had poor outcomes. Patients with stroke were having history of these complications. Long term monitoring is required in such patients to prevent stroke and mitigate adverse outcomes.
Keywords: COVID-19; Cardiac arrhythmia; Coronary Artery Disease; Deep vein thrombosis; Disseminated intravascular coagulation; Pulmonary embolism; Septic shock; Stroke.